J Tyler Haller1, Keaton Smetana2, Michael J Erdman3, Todd A Miano4, Heidi M Riha5, Alyssa Rinaldi2, Nitin Goyal6,7,8, G Morgan Jones1,6,8. 1. Department of Pharmacy, Methodist University Hospital, Memphis, TN, USA. 2. Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, USA. 3. Department of Pharmacy, University of Florida Health, Jacksonville, FL, USA. 4. Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. 5. Department of Pharmacy, Ascension St. Elizabeth Hospital, Appleton, WI, USA. 6. College of Medicine, University of Tennessee Health Sciences Center, Memphis, TN, USA. 7. Semmes-Murphey Brain and Spine Institute, Memphis, TN, USA. 8. College of Pharmacy, University of Tennessee Health Sciences Center, Memphis, TN, USA.
Abstract
BACKGROUND AND PURPOSE: While an association between hyperchloremia and worse outcomes, such as acute kidney injury and increased mortality, has been demonstrated in hemorrhagic stroke, it is unclear whether the same relationship exists after acute ischemic stroke. This study aims to determine the relationship between moderate hyperchloremia (serum chloride ≥115 mmol/L) and acute kidney injury in patients with ischemic stroke. METHODS: This is a multicenter, retrospective, propensity-matched cohort study of adults admitted for acute ischemic stroke. The primary objective was to determine the relationship between moderate hyperchloremia and acute kidney injury, as defined by the Acute Kidney Injury Network criteria. Secondary objectives included mortality and hospital length of stay. RESULTS: A total of 407 patients were included in the unmatched cohort (332 nonhyperchloremia and 75 hyperchloremia) and 114 patients (57 in each group) were matched based upon propensity scores. In the matched cohort, hyperchloremia was associated with an increased risk of acute kidney injury (relative risk 1.91 [95% confidence interval 1.01-3.59]) and a longer hospital length of stay (16 vs 12 days; P = .03). Mortality was higher in the hyperchloremia group (19.3% vs 10.5%, P = .19), but this did not reach statistical significance. CONCLUSIONS: In this study, hyperchloremia after ischemic stroke was associated with increased rates of acute kidney injury and longer hospital length of stay. Further research is needed to determine which interventions may increase chloride levels in patients with acute ischemic stroke and the association between hyperchloremia and clinical outcomes.
BACKGROUND AND PURPOSE: While an association between hyperchloremia and worse outcomes, such as acute kidney injury and increased mortality, has been demonstrated in hemorrhagic stroke, it is unclear whether the same relationship exists after acute ischemic stroke. This study aims to determine the relationship between moderate hyperchloremia (serum chloride ≥115 mmol/L) and acute kidney injury in patients with ischemic stroke. METHODS: This is a multicenter, retrospective, propensity-matched cohort study of adults admitted for acute ischemic stroke. The primary objective was to determine the relationship between moderate hyperchloremia and acute kidney injury, as defined by the Acute Kidney Injury Network criteria. Secondary objectives included mortality and hospital length of stay. RESULTS: A total of 407 patients were included in the unmatched cohort (332 nonhyperchloremia and 75 hyperchloremia) and 114 patients (57 in each group) were matched based upon propensity scores. In the matched cohort, hyperchloremia was associated with an increased risk of acute kidney injury (relative risk 1.91 [95% confidence interval 1.01-3.59]) and a longer hospital length of stay (16 vs 12 days; P = .03). Mortality was higher in the hyperchloremia group (19.3% vs 10.5%, P = .19), but this did not reach statistical significance. CONCLUSIONS: In this study, hyperchloremia after ischemic stroke was associated with increased rates of acute kidney injury and longer hospital length of stay. Further research is needed to determine which interventions may increase chloride levels in patients with acute ischemic stroke and the association between hyperchloremia and clinical outcomes.
Authors: Dariush Mozaffarian; Emelia J Benjamin; Alan S Go; Donna K Arnett; Michael J Blaha; Mary Cushman; Sandeep R Das; Sarah de Ferranti; Jean-Pierre Després; Heather J Fullerton; Virginia J Howard; Mark D Huffman; Carmen R Isasi; Monik C Jiménez; Suzanne E Judd; Brett M Kissela; Judith H Lichtman; Lynda D Lisabeth; Simin Liu; Rachel H Mackey; David J Magid; Darren K McGuire; Emile R Mohler; Claudia S Moy; Paul Muntner; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Graham Nichol; Latha Palaniappan; Dilip K Pandey; Mathew J Reeves; Carlos J Rodriguez; Wayne Rosamond; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Daniel Woo; Robert W Yeh; Melanie B Turner Journal: Circulation Date: 2015-12-16 Impact factor: 29.690
Authors: Minesh Khatri; Jonathan Himmelfarb; Derk Adams; Kyra Becker; W T Longstreth; David L Tirschwell Journal: J Stroke Cerebrovasc Dis Date: 2012-07-17 Impact factor: 2.136
Authors: Andrea Lassnigg; Daniel Schmidlin; Mohamed Mouhieddine; Lucas M Bachmann; Wilfred Druml; Peter Bauer; Michael Hiesmayr Journal: J Am Soc Nephrol Date: 2004-06 Impact factor: 10.121
Authors: Stuart A McCluskey; Keyvan Karkouti; Duminda Wijeysundera; Leonid Minkovich; Gordon Tait; W Scott Beattie Journal: Anesth Analg Date: 2013-06-11 Impact factor: 5.108
Authors: Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin Journal: Crit Care Date: 2007 Impact factor: 9.097
Authors: Sander Greenland; Stephen J Senn; Kenneth J Rothman; John B Carlin; Charles Poole; Steven N Goodman; Douglas G Altman Journal: Eur J Epidemiol Date: 2016-05-21 Impact factor: 8.082
Authors: Adnan I Qureshi; Wei Huang; Daniel F Hanley; Chung Y Hsu; Renee H Martin; Kunal Malhotra; Thorsten Steiner; Jose I Suarez; Haruko Yamamoto; Kazunori Toyoda Journal: Neurocrit Care Date: 2022-05-05 Impact factor: 3.532